Suppr超能文献

筋膜切除术和胶原酶注射术后复发性掌腱膜挛缩症在组织学上无法区分。

Recurrent Dupuytren's disease after fasciectomy and collagenase injection are histologically indistinguishable.

作者信息

Sanjuan-Cervero Rafael, Carrera-Hueso Francisco J, Vaquero-Perez Manuel, Montaner-Alonso Daniel

机构信息

Department of Orthopedic Surgery and Traumatology, Hospital de Denia, Alicante, Spain.

Department of Pharmacy, Hospital Dr. Moliner, Serra, Valencia, Spain.

出版信息

J Hand Surg Eur Vol. 2020 Jun;45(5):508-512. doi: 10.1177/1753193419900483. Epub 2020 Jan 24.

Abstract

The aim of this study was to determine whether recurrent Dupuytren's disease after collagenase treatment differs histologically from recurrence in those treated with fasciectomy. We carried out a prospective cohort study of patients with Dupuytren's disease who underwent fasciectomy to treat disease recurrence after previous treatment with collagenase or fasciectomy. The pathologists and statistician were blinded to the previous treatment. Longitudinal biopsy sections were stained with haematoxylin-eosin and the nodular zones were examined. Fifteen patients were studied: nine previously treated with collagenase and six previously treated with fasciectomy. There were no histological differences between the samples from the two groups of patients. Dupuytren's disease recurrences after fasciectomy and collagenase are histologically indistinguishable.

摘要

本研究的目的是确定胶原酶治疗后复发性掌腱膜挛缩症在组织学上是否与接受筋膜切除术治疗后的复发情况不同。我们对掌腱膜挛缩症患者进行了一项前瞻性队列研究,这些患者在先前接受胶原酶或筋膜切除术治疗后因疾病复发而接受了筋膜切除术。病理学家和统计学家对先前的治疗情况不知情。纵向活检切片用苏木精-伊红染色,并检查结节区域。共研究了15名患者:9名先前接受过胶原酶治疗,6名先前接受过筋膜切除术治疗。两组患者的样本在组织学上没有差异。筋膜切除术和胶原酶治疗后掌腱膜挛缩症的复发在组织学上无法区分。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验